• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX INC. INTUITRAK; BIFURCATED STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX INC. INTUITRAK; BIFURCATED STENT GRAFT Back to Search Results
Model Number 25-16-120BL - INTUITRAK
Device Problems Hole In Material (1293); Leak/Splash (1354); Torn Material (3024)
Patient Problems Aneurysm (1708); Failure of Implant (1924)
Event Date 11/04/2017
Event Type  Injury  
Manufacturer Narrative
The devices involved in the event will not be returned for evaluation, they remain implanted in the patient.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.
 
Event Description
The patient was initially implanted with a bifurcated stent and two infrarenal aortic extensions.On (b)(6) 2011 the patient was reported to have had a secondary procedure to treat a possible type 1b endoleak or iliac aneurysm growth.On (b)(6) 2017 a follow up computed tomography (ct) showed the patient had a tear in the bifurcated stent and aneurysm sac growth.The physician is planning to repair the endoleak.A secondary to date has not been scheduled or completed.The patient is currently reported to be in good condition and there have been no additional adverse events reported for this patient.
 
Manufacturer Narrative
Based on the information received at the completion of the clinical evaluation, there was unconfirmed reports to find substantial evidence to support the following reported events for the type iiib endoleak of the main body.Cumulative knowledge informed by past assessments of similar complaints was applied to a review of the available medical information.The most likely cause of the compromised stent graft integrity of the main body was either the burden of the multiple proximal extensions stents due to a hostile neck anatomy or the multiple distal iliac extensions upon the main body stent.Notably, there were bare metal stents in the proximal and distal areas.The most likely cause of the proximal loss of seal was the hostile neck anatomy.In addition, the most likely cause of the distal loss of seal was the tortuous iliac anatomy combined with suboptimal placement of the iliac stent with in the band at the implant.Additional findings were noted at 25 month post implant, in which patient had a coiling procedure done to address a type 1a endoleak that was corrected with a non-endologix stent, along with a non-endologix limb placement for a type 1b endoleak.At 35 months post implant, patient had a open repair done for the type 1a endoleak with a dacron tape procedure.The procedure related harms could not be ascertain due to lack of medical information surrounding the event.There was no evidence of a secondary procedure.However, it was reported that the patient condition is stable.To date there has been no reports of further negative patient condition.A root cause investigation was carried out for all afx complaints having an identified failure mode of a type iiib endoleak.Endologix implemented the following corrective actions with the intent of reducing type iiib endoleak events; upgraded graft material (i.E.Duraply) and updates to the ifu and additional physician training.The change to duraply graft material and the ifu changes were put in place july 2014.The type iiib endoleak rate for afx manufactured and implanted before these corrective actions were put in place is trending at 2.5%.Since the corrective actions were implemented, the type iiib endoleak events reported for afx devices has been reduced to <0.2%.The devices remain implanted in the patient and were not returned and no evaluation was completed.These types of events will be monitored and trended as part of the quality system.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INTUITRAK
Type of Device
BIFURCATED STENT GRAFT
Manufacturer (Section D)
ENDOLOGIX INC.
2 musick
irvine CA 92618
Manufacturer Contact
victor arellano
2 musick
irvine, CA 92618
9495984671
MDR Report Key7068731
MDR Text Key93281313
Report Number2031527-2017-00644
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/04/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/31/2010
Device Model Number25-16-120BL - INTUITRAK
Device Lot NumberW09-1102-011
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 11/04/2017
Initial Date FDA Received11/29/2017
Supplement Dates Manufacturer Received11/04/2017
Supplement Dates FDA Received02/22/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/06/2009
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age85 YR
-
-